UK: Carlyle to bolster global healthcare franchise with acquisition of Abingworth

UK-based transatlantic life sciences investment firm, Abingworth, is to be acquired by global investment firm Carlyle. Abingworth has over US$2bn in assets under management (AUM). The transaction will bolster Carlyle’s global healthcare franchise and enable it to operate across the full risk-return spectrum of life sciences and healthcare investing, from venture capital to buyouts. Abingworth…

You must be a HMI Subscriber to view this content.

Subscribe Now »